LAS VEGAS, NV–Cell MedX Corp. (OTCQB: CMXC) (the “Company”) is pleased to announce that it has received the first results of the analysis of metabolomic assays taken during the Phase 1 pilot clinical trial. The pilot clinical discovery phase trial…
LAS VEGAS, NV–Cell MedX Corp. (OTC PINK: CMXC) (OTCQB: CMXC), (the “Company”) is pleased to announce that the Company has received an approval from the OTC Markets to upgrade to the OTCQB venture stage marketplace. The Company will transition from…